MAM
KURA icon

Meeder Asset Management’s Kura Oncology KURA Stock Holding History

Meeder Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,069
Closed -$155K – 2049
2020
Q3 		$155K Buy
5,069
+40
+0.8% +$883 0.01% 669
2020
Q2 		$82K Buy
5,029
+4,619
+1,127% +$66.6K 0.01% 804
2020
Q1 		$4K Sell
410
-2,277
-85% -$26.1K ﹤0.01% 1868
2019
Q4 		$37K Sell
2,687
-320
-11% -$4.74K ﹤0.01% 1128
2019
Q3 		$46K Buy
3,007
+1,073
+55% +$19.1K ﹤0.01% 1042
2019
Q2 		$38K Buy
1,934
+1,204
+165% +$20K ﹤0.01% 1028
2019
Q1 		$12K Sell
730
-515
-41% -$7.93K ﹤0.01% 1195
2018
Q4 		$18K Sell
1,245
-94
-7% -$1.25K ﹤0.01% 1090
2018
Q3 		$23K Buy
1,339
+1,119
+509% +$21.5K ﹤0.01% 997
2018
Q2 		$4K Sell
220
-471
-68% -$7.98K ﹤0.01% 1317
2018
Q1 		$12K Buy
691
+613
+786% +$11.9K ﹤0.01% 1019
2017
Q4 		$2K Sell
78
-147
-65% -$2.17K ﹤0.01% 1493
2017
Q3 		$3K Buy
+225
New +$2.11K ﹤0.01% 1378

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Meeder Asset Management's KURA Position: Q4 2020 in Review

Meeder Asset Management sold out of Kura Oncology (KURA) in Q4 2020, closing a stake of 5,069 shares — an estimated $155K sold.

Meeder Asset Management first reported a position in KURA in Q3 2017 and held it in 13 quarters. The position peaked at $155K in Q3 2020. 198 funds tracked by Wall St. Rank hold KURA as of Q4 2020.

  • Meeder Asset Management reported no remaining Kura Oncology position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 5,069 Kura Oncology shares in Q4 2020, an estimated $155K.
  • Meeder Asset Management first reported a position in Kura Oncology in Q3 2017 and held it in 13 quarters.
  • Meeder Asset Management's Kura Oncology position peaked at $155K in Q3 2020.
  • 198 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.